Iron chelation cancer therapy using hydrophilic block copolymers conjugated with deferoxamine

Cancer cells have high iron requirements due to their rapid growth and proliferation. Iron depletion using iron chelators has a potential in cancer treatment. Previous studies have demonstrated that deferoxamine (DFO) specifically chelates Fe(III) and exhibited antitumor activity in clinical studies...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancer Sci
Autors principals: Komoto, Kana, Nomoto, Takahiro, El Muttaqien, Sjaikhurrizal, Takemoto, Hiroyasu, Matsui, Makoto, Miura, Yutaka, Nishiyama, Nobuhiro
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2020
Matèries:
Drug Discovery and Delivery
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7780030/
https://ncbi.nlm.nih.gov/pubmed/32770631
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.14607
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars